Literature DB >> 18343475

Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging.

Jafar Kafaie1, Rujun Song, Levon Abrahamyan, Andrew J Mouland, Michael Laughrea.   

Abstract

Retroviral genomic RNA (gRNA) dimerization appears essential for viral infectivity, and the nucleocapsid protein (NC) of human immunodeficiency virus type 1 (HIV-1) facilitates HIV-1 gRNA dimerization. To identify the relevant and dispensable positions of NC, 34 of its 55 residues were mutated, individually or in small groups, in a panel of 40 HIV-1 mutants prepared by site-directed mutagenesis. It was found that the amino-terminus, the proximal zinc finger, the linker, and the distal zinc finger of NC each contributed roughly equally to efficient HIV-1 gRNA dimerization. The N-terminal and linker segments appeared to play predominantly electrostatic and steric roles, respectively. Mutating the hydrophobic patch of either zinc finger, or substituting alanines for their glycine doublet, was as disabling as deleting the corresponding finger. Replacing the CysX(2)CysX(4)HisX(4)Cys motif of either finger by CysX(2)CysX(4)CysX(4)Cys or CysX(2)CysX(4)HisX(4)His, interchanging the zinc fingers or, replacing one zinc finger by a copy of the other one, had generally intermediate effects; among these mutations, the His23-->Cys substitution in the N-terminal zinc finger had the mildest effect. The charge of NC could be increased or decreased by up to 18%, that of the linker could be reduced by 75% or increased by 50%, and one or two electric charges could be added or subtracted from either zinc finger, without affecting gRNA dimerization. Shortening, lengthening, or making hydrophobic the linker was as disabling as deleting the N-terminal or the C-terminal zinc finger, but a neutral and polar linker was innocuous. The present work multiplies by 4 and by 33 the number of retroviral and lentiviral NC mutations known to inhibit gRNA dimerization, respectively. It shows the first evidence that gRNA dimerization can be inhibited by: 1) mutations in the N-terminus or the linker of retroviral NC; 2) mutations in the proximal zinc finger of lentiviral NC; 3) mutations in the hydrophobic patch or the conserved glycines of the proximal or the distal retroviral zinc finger. Some NC mutations impaired gRNA dimerization more than mutations inactivating the viral protease, indicating that gRNA dimerization may be stimulated by the NC component of the Gag polyprotein. Most, but not all, mutations inhibited gRNA packaging; some had a strong effect on virus assembly or stability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343475     DOI: 10.1016/j.virol.2008.02.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

Review 1.  HIV-1 assembly, budding, and maturation.

Authors:  Wesley I Sundquist; Hans-Georg Kräusslich
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 2.  Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Robert J Gorelick
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 3.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 4.  Diverse interactions of retroviral Gag proteins with RNAs.

Authors:  Alan Rein; Siddhartha A K Datta; Christopher P Jones; Karin Musier-Forsyth
Journal:  Trends Biochem Sci       Date:  2011-05-06       Impact factor: 13.807

Review 5.  Cell biology of retroviral RNA packaging.

Authors:  Nolwenn Jouvenet; Sébastien Lainé; Lucie Pessel-Vivares; Marylène Mougel
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

6.  HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.

Authors:  Serena Bernacchi; Ekram W Abd El-Wahab; Noé Dubois; Marcel Hijnen; Redmond P Smyth; Johnson Mak; Roland Marquet; Jean-Christophe Paillart
Journal:  RNA Biol       Date:  2016-11-14       Impact factor: 4.652

7.  C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.

Authors:  Dominic F Qualley; Kristen M Stewart-Maynard; Fei Wang; Mithun Mitra; Robert J Gorelick; Ioulia Rouzina; Mark C Williams; Karin Musier-Forsyth
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

8.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

9.  Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation.

Authors:  Růžena Píchalová; Tibor Füzik; Barbora Vokatá; Michaela Rumlová; Manuel Llano; Alžběta Dostálková; Ivana Křížová; Tomáš Ruml; Pavel Ulbrich
Journal:  Virology       Date:  2018-06-12       Impact factor: 3.616

10.  Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning.

Authors:  Martin Lehmann; Miroslav P Milev; Levon Abrahamyan; Xiao-Jian Yao; Nelly Pante; Andrew J Mouland
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.